FDA Approval Should Be a Suggestion, Not a Requirement

In November, doctors attempted to cure a 44-year old patient's Hunter syndrome, a genetic disorder that affects the body's ability to metabolize a specific macromolecule. If this approach works, it will be a clinical milestone and spark the hope of patients afflicted by similar metabolic disorders. Unfortunately, this hope might be misplaced, thanks to FDA approval delays.